Vivek Ramaswamy's company spent $70K lobbying Washington on Covid-19 drugs. He's now campaigning against 'Covid ideology.'

Vivek Ramaswamy's company spent $70K lobbying Washington on Covid-19 drugs. He's now campaigning against 'Covid ideology.'

Roivant Sciences paid Baker Donelson and Tiber Creek Group $70,000 to lobby the White House and NIH on Covid drug approval as Ramaswamy now attacks Acton's pandemic record.

NEW: Vivek Ramaswamy’s Company Spent Over $70,000 Lobbying the Federal Government for Development & Approval of COVID-19 Drugs - Ohio Democrats

Columbus, Ohio- New reporting from Politico’s Influence newsletter revealed that Vivek Ramaswamy’s company spent more than $70,000 lobbying the federal government for the development and approval of COVID-19 drugs. Federal lobbying records show Ramaswamy’s company spent approximately $50,000 lobbying the National Institutes of Health and the Executive Office of the President as well as approximately $20,000 lobbying Congress. This new reporting …